• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Liquid biopsy in lymphoma.

作者信息

Rossi Davide, Spina Valeria, Bruscaggin Alessio, Gaidano Gianluca

机构信息

Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland

Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.

出版信息

Haematologica. 2019 Apr;104(4):648-652. doi: 10.3324/haematol.2018.206177. Epub 2019 Mar 7.

DOI:10.3324/haematol.2018.206177
PMID:30846503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6442975/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c3/6442975/7399100c5194/104648.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c3/6442975/7399100c5194/104648.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10c3/6442975/7399100c5194/104648.fig1.jpg

相似文献

1
Liquid biopsy in lymphoma.淋巴瘤中的液体活检
Haematologica. 2019 Apr;104(4):648-652. doi: 10.3324/haematol.2018.206177. Epub 2019 Mar 7.
2
The development of liquid biopsy for research and clinical practice in lymphomas: Report of the 15-ICML workshop on ctDNA.液体活检在淋巴瘤研究和临床实践中的发展：ctDNA 第 15 次 ICML 研讨会报告。
Hematol Oncol. 2020 Feb;38(1):34-37. doi: 10.1002/hon.2704. Epub 2019 Dec 30.
3
Towards the better diagnosis of lymphoma.迈向淋巴瘤的更好诊断。
Nature. 2018 Nov;563(7731):S38-S40. doi: 10.1038/d41586-018-07360-7.
4
Methods for Measuring ctDNA in Lymphomas.淋巴瘤中循环肿瘤DNA（ctDNA）的检测方法
Methods Mol Biol. 2019;1881:253-265. doi: 10.1007/978-1-4939-8876-1_19.
5
Ultrasensitive Detection of Circulating Tumor DNA in Lymphoma via Targeted Hybridization Capture and Deep Sequencing of Barcoded Libraries.通过靶向杂交捕获和条形码文库深度测序对淋巴瘤中循环肿瘤DNA进行超灵敏检测。
Methods Mol Biol. 2019;1956:383-435. doi: 10.1007/978-1-4939-9151-8_20.
6
Updates on Circulating Tumor DNA Assessment in Lymphoma.淋巴瘤循环肿瘤DNA评估的最新进展
Curr Hematol Malig Rep. 2018 Oct;13(5):348-355. doi: 10.1007/s11899-018-0468-4.
7
[Possibilities of liquid biopsy in gastric cancer].[液体活检在胃癌中的应用可能性]
Vopr Onkol. 2016;62(4):379-85.
8
Liquid Biopsy: A New Tool in Oncology.液体活检：肿瘤学中的一种新工具。
Acta Cytol. 2019;63(6):448. doi: 10.1159/000501355. Epub 2019 Jul 2.
9
Potential of circulating biomarkers in liquid biopsy diagnostics.循环生物标志物在液体活检诊断中的潜力。
Biotechniques. 2018 Oct;65(4):187-189. doi: 10.2144/btn-2018-0093.
10
A fluid solution: Scientists explore use of liquid biopsy tests to find cancer DNA.一种液体解决方案：科学家探索使用液体活检检测来寻找癌症DNA。
Cancer. 2018 May 1;124(9):1853-1854. doi: 10.1002/cncr.31387.

引用本文的文献

1
Liquid Biopsy in B and T Cell Lymphomas: From Bench to Bedside.B细胞和T细胞淋巴瘤的液体活检：从实验台到病床旁
Int J Mol Sci. 2025 May 19;26(10):4869. doi: 10.3390/ijms26104869.
2
Reliable detection of CNS lymphoma-derived circulating tumor DNA in cerebrospinal fluid using multi-biomarker NGS profiling: insights from a real-world study.使用多生物标志物NGS分析可靠检测脑脊液中中枢神经系统淋巴瘤来源的循环肿瘤DNA：一项真实世界研究的见解
Biomark Res. 2025 May 9;13(1):71. doi: 10.1186/s40364-025-00777-z.
3
Circulating tumor DNA in lymphoma: technologies and applications.

本文引用的文献

1
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.循环肿瘤 DNA 测量作为弥漫性大 B 细胞淋巴瘤的早期预后预测指标。
J Clin Oncol. 2018 Oct 1;36(28):2845-2853. doi: 10.1200/JCO.2018.78.5246. Epub 2018 Aug 20.
2
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma.基因组分析揭示了滤泡性淋巴瘤肿瘤内的空间异质性。
Leukemia. 2018 May;32(5):1261-1265. doi: 10.1038/s41375-018-0043-y. Epub 2018 Feb 8.
3
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
淋巴瘤中的循环肿瘤DNA：技术与应用
J Hematol Oncol. 2025 Mar 11;18(1):29. doi: 10.1186/s13045-025-01673-7.
4
Advanced NGS analysis of cell-free tumor DNA supports clonal relation to primary high-grade B-cell lymphoma lesion and CNS relapse despite MRI negativity.对游离肿瘤DNA进行的高级二代测序分析支持其与原发性高级别B细胞淋巴瘤病灶及中枢神经系统复发存在克隆关系，尽管磁共振成像结果为阴性。
Diagn Pathol. 2025 Feb 4;20(1):14. doi: 10.1186/s13000-025-01609-2.
5
Molecular measurable residual disease by immunoglobulin gene rearrangements on circulating tumor DNA predicts outcome in diffuse large B-cell lymphoma.通过循环肿瘤DNA上免疫球蛋白基因重排检测的分子可测量残留病可预测弥漫性大B细胞淋巴瘤的预后。
Haematologica. 2025 Jul 1;110(7):1573-1583. doi: 10.3324/haematol.2024.286331. Epub 2024 Dec 19.
6
Mutational heterogeneity in large B-cell lymphoma: insights from paired biopsies.大B细胞淋巴瘤中的突变异质性：来自配对活检的见解
Ann Hematol. 2024 Dec;103(12):5835-5848. doi: 10.1007/s00277-024-06108-w. Epub 2024 Dec 7.
7
Clinical application of circulating cell-free lymphoma DNA for fast and precise diagnosis of Burkitt lymphoma: Precision medicine for sub-Saharan Africa.循环游离淋巴瘤DNA在伯基特淋巴瘤快速精准诊断中的临床应用：撒哈拉以南非洲地区的精准医学
Camb Prism Precis Med. 2023 Jan 13;1:e13. doi: 10.1017/pcm.2023.1. eCollection 2023.
8
Non-invasive detection of lymphoma with circulating tumor DNA features and protein tumor markers.利用循环肿瘤DNA特征和蛋白质肿瘤标志物对淋巴瘤进行无创检测。
Front Oncol. 2024 Jan 19;14:1341997. doi: 10.3389/fonc.2024.1341997. eCollection 2024.
9
Measurable Residual Disease Monitoring in Lymphoma.淋巴瘤中的可测量残留病监测
Curr Hematol Malig Rep. 2023 Dec;18(6):292-304. doi: 10.1007/s11899-023-00715-6. Epub 2023 Nov 6.
10
Neurosurgical Management of Central Nervous System Lymphoma: Lessons Learnt from a Neuro-Oncology Multidisciplinary Team Approach.中枢神经系统淋巴瘤的神经外科治疗：从神经肿瘤多学科团队方法中汲取的经验教训。
J Pers Med. 2023 Apr 30;13(5):783. doi: 10.3390/jpm13050783.
循环肿瘤 DNA 揭示经典型霍奇金淋巴瘤的遗传学、克隆进化和残留疾病。
Blood. 2018 May 31;131(22):2413-2425. doi: 10.1182/blood-2017-11-812073. Epub 2018 Feb 15.
4
Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤循环DNA中疾病特异性MYD88突变的临床意义
Cancer Sci. 2018 Jan;109(1):225-230. doi: 10.1111/cas.13450. Epub 2017 Dec 23.
5
Diffuse large B-cell lymphoma genotyping on the liquid biopsy.弥漫性大 B 细胞淋巴瘤的液体活检基因分型。
Blood. 2017 Apr 6;129(14):1947-1957. doi: 10.1182/blood-2016-05-719641. Epub 2017 Jan 17.
6
Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?霍奇金淋巴瘤的反应适应性一线治疗：我们做到了吗？
Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):316-322. doi: 10.1182/asheducation-2016.1.316.
7
Response Assessment Criteria and Their Applications in Lymphoma: Part 2.淋巴瘤的疗效评估标准及其应用：第2部分。
J Nucl Med. 2017 Jan;58(1):13-22. doi: 10.2967/jnumed.116.184242. Epub 2016 Nov 22.
8
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.循环肿瘤 DNA 揭示淋巴瘤中独特的生物学亚型和基因组进化模式。
Sci Transl Med. 2016 Nov 9;8(364):364ra155. doi: 10.1126/scitranslmed.aai8545.
9
Detection of L265P MYD-88 mutation in a series of clonal B-cell lymphocytosis of marginal zone origin (CBL-MZ).在一系列边缘区起源的克隆性B细胞淋巴细胞增多症（CBL-MZ）中检测L265P MYD-88突变。
Hematol Oncol. 2017 Dec;35(4):542-547. doi: 10.1002/hon.2361. Epub 2016 Oct 13.
10
Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphoma.经典型霍奇金淋巴瘤患者肿瘤及游离循环DNA中输出蛋白1复发性突变的检测及预后价值
Haematologica. 2016 Sep;101(9):1094-101. doi: 10.3324/haematol.2016.145102. Epub 2016 Jun 13.